(Q46966092)

26 December 2017

title

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. (English)

1 reference

26 December 2017

chronic obstructive pulmonary disease

main subject

0 references

author name string

Jadwiga A Wedzicha

1

1 reference

26 December 2017

Peter M A Calverley

2

1 reference

26 December 2017

Terence A Seemungal

3

1 reference

26 December 2017

Gerry Hagan

4

1 reference

26 December 2017

Zainab Ansari

5

1 reference

26 December 2017

Robert A Stockley

6

1 reference

26 December 2017

INSPIRE Investigators

7

1 reference

26 December 2017

language of work or name

English

0 references

publication date

4 October 2007

1 reference

26 December 2017

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

26 December 2017

volume

177

1 reference

26 December 2017

page(s)

19-26

1 reference

26 December 2017

issue

1

1 reference

26 December 2017

Chronic obstructive pulmonary disease: current burden and future projections.

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200707-973OC

Epidemiology and costs of chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200707-973OC

Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200707-973OC

Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200707-973OC

Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200707-973OC

Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200707-973OC

Impact of preventing exacerbations on deterioration of health status in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200707-973OC

The costs of exacerbations in chronic obstructive pulmonary disease (COPD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200707-973OC

Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200707-973OC

COPD exacerbations. 4: Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200707-973OC

Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200707-973OC

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200707-973OC

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200707-973OC

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200707-973OC

Investigating new standards for prophylaxis in reduction of exacerbations--the INSPIRE study methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200707-973OC

Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200707-973OC

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200707-973OC

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200707-973OC

Toward a consensus definition for COPD exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200707-973OC

Statistical treatment of exacerbations in therapeutic trials of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200707-973OC

Health status measurement in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200707-973OC

The nature of small-airway obstruction in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200707-973OC

Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200707-973OC

Anti-inflammatory effects of inhaled corticosteroids in chronic obstructive pulmonary disease: similarities and differences to asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200707-973OC

Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200707-973OC

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200707-973OC

10.1164/RCCM.200707-973OC

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

PubMed ID

17916806

1 reference

26 December 2017